Akorn Inc logo

AKRX - Akorn Inc Share Price

$1.31 0.0  0.0%

Last Trade - 6:05pm

Sector
Healthcare
Size
Small Cap
Market Cap £126.7m
Enterprise Value £611.9m
Revenue £516.3m
Position in Universe 3970th / 6416
Bullish
Bearish
Unlock AKRX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AKRX Revenue Unlock AKRX Revenue

Net Income

AKRX Net Income Unlock AKRX Revenue

Normalised EPS

AKRX Normalised EPS Unlock AKRX Revenue

PE Ratio Range

AKRX PE Ratio Range Unlock AKRX Revenue

Dividend Yield Range

AKRX Dividend Yield Range Unlock AKRX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AKRX EPS Forecasts Unlock AKRX Revenue
Profile Summary

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated January 20, 1971
Public Since November 24, 2004
No. of Shareholders: 250
No. of Employees: 2,191
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 126,145,832
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AKRX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AKRX
Upcoming Events for AKRX
Similar to AKRX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.